The company’s net earnings total $953 million, up from $864 million during the same period last year. Medtronic’s net sales reached $4.1 billion, up nearly 1.9 percent from last year’s $4 billion.
Revenue from spine, including core spine and BMP, dropped to $765 million from $786 million during the first quarter of 2013. BMP alone decreased 12 percent from the same period last year.
All other areas of Medtronic sales, including coronary, endovascular and surgical technologies, increased.
More Articles on Devices:
FDA Clears CoAlign Innovations’ AccuLIF Interbody Fusion Devices to Market
Smith & Nephew Allowed to Promote KFx Medical Rotator Cuff Repair Device
Australian Government Warns of LMT Surgical’s Arthroplasty Device Safety
